Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil versus placebo for prevention of fetal distress and reduction of emergency cesarean section risk
IRCT20120215009014N435Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in fetal heart rate abnormality during labor (NRFS) and obstetric emergency comparing Sildenafil with Placebo (2 arms). Primary endpoints: Incidence of fetal distress and Incidence of emergency cesarean section. Started Aug 2022; status: completed.
02
Drugs
sildenafil
03
Conditions
fetal heart rate abnormality during labor (NRFS)obstetric emergency
Beyond the preview
Go deeper on IRCT20120215009014N435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N435.